EndoGene.Bio
Paris, France
EndoGene.Bio wants to use precision medicine to transform how endometriosis is diagnosed and treated. We'll start with accelerating the diagnosis of endometriosis from months to weeks through a non-invasive endometriosis diagnostic test. We're developing this test based on proprietary epigenetic biomarkers in menstrual blood.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- www.endogene.bio/
Only accessible to MedStartr community members.
Join nowWhat do you think of EndoGene.Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now